|
About the modeling strategy category
|
|
0
|
3921
|
July 13, 2018
|
|
RMS Describing, Resampling, Validating, and Simplifying the Model
|
|
84
|
32447
|
February 2, 2023
|
|
Covariates in a Case Crossover Design
|
|
0
|
43
|
February 2, 2023
|
|
Bayesian Biostatistical Modeling Plan
|
|
3
|
281
|
February 2, 2023
|
|
Within-between effects, splines and longitudinal data
|
|
0
|
66
|
February 1, 2023
|
|
RMS Multivariable Modeling Strategies
|
|
37
|
23693
|
January 26, 2023
|
|
RMS General Regression
|
|
52
|
24311
|
January 25, 2023
|
|
ANCOVA that handles pseudoreplication?
|
|
0
|
58
|
January 25, 2023
|
|
Rescue analysis for % change from baseline as an outcome in RCT
|
|
16
|
557
|
January 16, 2023
|
|
Effectiveness of Paxlovid a retrospective study
|
|
5
|
184
|
January 11, 2023
|
|
Challenges to variable selection
|
|
8
|
4871
|
January 6, 2023
|
|
RMS Discussions
|
|
298
|
55541
|
December 17, 2022
|
|
Advice regarding analysis plan for a study
|
|
2
|
473
|
December 9, 2022
|
|
RMS Missing Data
|
|
18
|
19928
|
December 6, 2022
|
|
Missing data and prediction modelling
|
|
1
|
383
|
December 4, 2022
|
|
Troponin, its use and misuse to rule-out and rule-in heart attacks
|
|
57
|
10114
|
November 28, 2022
|
|
Multiple observations per patient and reducing to one one observation per patient
|
|
6
|
464
|
November 23, 2022
|
|
Generalized Additive Models with R gam
|
|
1
|
538
|
November 22, 2022
|
|
Categorization of continuous outcome and odds ratio
|
|
2
|
349
|
November 8, 2022
|
|
Clarification on model selection example in BBR Notes
|
|
3
|
2513
|
March 26, 2021
|
|
Regression Modeling Strategies: Overview of Maximum Likelihood Estimation
|
|
0
|
317
|
November 2, 2022
|
|
Pre-post study design with data not missing at random and multiple observations per patient
|
|
0
|
152
|
November 1, 2022
|
|
RMS Ordinal Regression for Continuous Y
|
|
25
|
20285
|
October 23, 2022
|
|
Prediction - risk vs treatment effect modelling approaches
|
|
1
|
379
|
October 19, 2022
|
|
Estimands from Bayesian Constrained Partial Proportional Odds Model in rmsb
|
|
1
|
313
|
October 4, 2022
|
|
Model selection and assessment of model fit
|
|
22
|
9370
|
October 2, 2022
|
|
Could cardiovescular risk nomogram be supirior than the Framingham Risk Score? If so, what could be the reasons?
|
|
0
|
233
|
September 20, 2022
|
|
How to best handle limits of detection with continuous predictors?
|
|
8
|
829
|
August 31, 2022
|
|
Guidance in dose volume histogram analysis
|
|
3
|
2147
|
August 29, 2022
|
|
Patient-specific treatment effects in RCTs: why should one present them?
|
|
1
|
1542
|
August 13, 2022
|